Pancreatic Adenocarcinoma

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for pancreatic adenocarcinoma: a review

SEE THE STUDY

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for advanced pancreatic and periampullary adenocarcinoma

SEE THE STUDY

EUS-guided radiofrequency ablation of small pancreatic adenocarcinoma: a new therapeutic option for patients unfit for surgery

SEE THE STUDY

Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma

SEE THE STUDY

EUS-guided radiofrequency ablation of the porcine pancreas

SEE THE STUDY

A single-center experience of chemotherapy combined with radiofrequency ablation and immunotherapy in patients with locally advanced/metastatic pancreatic ductal adenocarcinoma

SEE THE STUDY

One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequency ablation

SEE THE STUDY

EUS-guided radiofrequency ablation for pancreatic adenocarcinoma

SEE THE STUDY

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for pancreatic adenocarcinoma: a review

SEE THE STUDY

EUS-guided RF ablation doubles survival for unresectable pancreatic cancer

SEE THE STUDY

Endoscopic ultrasound-guided radiofrequency ablation for pancreatic adenocarcinoma

SEE THE STUDY

Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma

SEE THE STUDY

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) and endoscopic ultrasound-guided ethanol ablation (EUS-EA) of pancreatic neuroendocrine tumors and adenocarcinoma: a prospective multicenter study

SEE THE STUDY

Assessing EUS-guided radiofrequency ablation in unresectable pancreatic ductal adenocarcinoma: a single-center historic cohort study

SEE THE STUDY

EUS-guided radiofrequency ablation for pancreatic adenocarcinoma

SEE THE STUDY

Harnessing endoscopic ultrasound-guided radiofrequency ablation to reshape the pancreatic ductal adenocarcinoma microenvironment and elicit systemic immunomodulation

SEE THE STUDY

Assessing the efficacy and safety of EUS-RFA in pancreatic adenocarcinoma: a systematic review and meta-analysis

SEE THE STUDY

EUS-Guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for unresectable pancreatic cancer

SEE THE STUDY

Endoscopic immuno-oncology: a new frontier in treatment of pancreatic cancer

SEE THE STUDY